Cargando…
Potential risk of tamoxifen: gut microbiota and inflammation in mice with breast cancer
OBJECTIVE: Tamoxifen is an effective anti-tumor medicine, but evidence has been provided on tamoxifen-related inflammation as well as its impact on gut microbiota. In this study, we aimed to investigate tamoxifen-induced gut microbiota and inflammation alteration. METHODS: We established a BC xenogr...
Autores principales: | Li, Hailong, Gao, Xiufei, Chen, Yian, Wang, Mengqian, Xu, Chuchu, Yu, Qinghong, Jin, Ying, Song, Jiaqing, Zhu, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353877/ https://www.ncbi.nlm.nih.gov/pubmed/37469407 http://dx.doi.org/10.3389/fonc.2023.1121471 |
Ejemplares similares
-
Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential
por: Xu, Chuchu, et al.
Publicado: (2023) -
The expression of androgen receptor in triple-negative breast cancer and the effect of a traditional Chinese medicine formula on disease-free survival
por: Yu, Linghong, et al.
Publicado: (2022) -
GeneChip expression profiling identified OLFML2A as a potential therapeutic target in TNBC cells
por: Gao, Xiufei, et al.
Publicado: (2022) -
Efficacy and safety of microwave ablation for benign breast lesions: a systematic review and meta-analysis
por: Xu, Chuchu, et al.
Publicado: (2022) -
Baihe Zhimu formula attenuates the efficacy of tamoxifen against breast cancer in mice through modulation of CYP450 enzymes
por: Li, Hailong, et al.
Publicado: (2019)